A detailed history of Ubs Oconnor LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Ubs Oconnor LLC holds 510,701 shares of CNTB stock, worth $643,483. This represents 0.04% of its overall portfolio holdings.

Number of Shares
510,701
Holding current value
$643,483
% of portfolio
0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.01 - $1.74 $50,994 - $87,852
-50,490 Reduced 9.0%
510,701 $888,000
Q4 2023

Feb 14, 2024

SELL
$0.7 - $2.06 $29,896 - $87,980
-42,709 Reduced 7.07%
561,191 $662,000
Q2 2023

Aug 14, 2023

BUY
$1.01 - $1.25 $609,939 - $754,875
603,900 New
603,900 $670 Million
Q1 2023

May 15, 2023

BUY
$0.82 - $1.32 $5,378 - $8,657
6,559 Added 1.16%
574,148 $574,000
Q4 2022

Feb 14, 2023

SELL
$0.64 - $1.31 $29,658 - $60,708
-46,342 Reduced 7.55%
567,589 $0
Q3 2022

Nov 14, 2022

SELL
$0.8 - $1.65 $30,060 - $61,998
-37,575 Reduced 5.77%
613,931 $792 Million
Q2 2022

Aug 12, 2022

BUY
$0.56 - $3.25 $364,843 - $2.12 Million
651,506 New
651,506 $566,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $69.3M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.